Lauren E. Bufe
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Advanced Breast Cancer Therapies, Cancer Immunotherapy and Biomarkers, Insect Resistance and Genetics, Cancer Genomics and Diagnostics
Most-Cited Works
- → CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2017)756 cited
- → Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade(2017)193 cited
- → Synergy of WEE1 and mTOR Inhibition in Mutant KRAS -Driven Lung Cancers(2017)37 cited
- → Timing of valproic acid in acute lung injury: prevention is the best therapy?(2017)16 cited
- → Data from CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2023)
- → Supplemental Methods, Supplemental Tables 1-4, Supplemental Figures 1-8 from Synergy of WEE1 and mTOR Inhibition in Mutant <i>KRAS</i>-Driven Lung Cancers(2023)
- → Supplementary Data from CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2023)
- → Data from Synergy of WEE1 and mTOR Inhibition in Mutant <i>KRAS</i>-Driven Lung Cancers(2023)